Rani Therapeutics Holdings RANI
NASDAQ RANI
$0.84 +0.02 (+2.51%)
At close: Sep 11, 2026 · 4:00 PM EDT

Rani Therapeutics Holdings (RANI) Asset Utilization Ratio (2021 - 2026)

Rani Therapeutics Holdings (RANI) posted Asset Utilization Ratio of 0.09 for Q2 2026, up 50.86% on a QoQ basis from 0.06 in Q1 2026, and up 47.91% year-over-year from 0.06 in Q2 2025.

Analysis

Rani Therapeutics Holdings (RANI) Asset Utilization Ratio (2021 - 2026) Analysis & Trends

Rani Therapeutics Holdings has reported Asset Utilization Ratio for 5 years, with the latest figure at 0.09 in Q2 2026.

  • On a quarterly basis, Asset Utilization Ratio rose 47.91% year-over-year to 0.09 in Q2 2026; TTM through Jun 2026 was 0.09, a 47.91% increase from a year earlier, with the FY2025 full-year figure at 0.03, up 57.68% from the prior year.
  • Asset Utilization Ratio was 0.09 for Q2 2026 at Rani Therapeutics Holdings, up from 0.06 in the prior quarter.
  • The five-year high for Asset Utilization Ratio was 0.09 in Q3 2025, with the low at 0.02 in Q2 2022.
  • Average Asset Utilization Ratio over 4 years is 0.05, with a median of 0.05 recorded in 2025.
  • The sharpest annual moves came in 2025 and 2026: Asset Utilization Ratio soared 85.22% in 2025, then soared 45.21% in 2026.
  • Over 4 years, Asset Utilization Ratio stood at 0.02 in 2022, then soared by 43.62% to 0.03 in 2024, then jumped by 85.22% to 0.05 in 2025, then jumped by 82.18% to 0.09 in 2026.
  • The last three Asset Utilization Ratio figures came in at 0.09 (Q2 2026), 0.06 (Q1 2026), and 0.05 (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Amgen 203.97 Bn 189.99 Bn 7.24 Bn 0.40
2 Gilead Sciences 178.74 Bn 175.56 Bn 6.22 Bn 0.58
3 Vertex Pharmaceuticals 130.73 Bn 122.88 Bn 2.84 Bn 0.47
4 Regeneron Pharmaceuticals 80.42 Bn 72.42 Bn 3.93 Bn 0.38
5 Argenx Se 60.40 Bn 55.21 Bn 1.37 Bn -
6 Moderna 57.65 Bn 52.52 Bn 52.00 Mn 0.20
7 Alnylam Pharmaceuticals 33.37 Bn 30.07 Bn 992.69 Mn 0.90
8 Biogen 32.15 Bn 30.86 Bn 1.96 Bn 0.33
9 Roivant Sciences 29.58 Bn 29.58 Bn 1.16 Mn 0.00
10 Rani Therapeutics Holdings 157.97 Mn 157.97 Mn - 0.09
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.09
Mar 31, 2026 0.06
Dec 31, 2025 0.05
Sep 30, 2025 0.09
Jun 30, 2025 0.06
Mar 31, 2025 0.04
Dec 31, 2024 0.03
Jun 30, 2022 0.02
Dec 31, 2021 0.02
Sep 30, 2021 0.03